Cargando…

The Effect of Eplerenone on Adenosine Formation in Humans In Vivo: A Double-Blinded Randomised Controlled Study

BACKGROUND: It has been suggested that mineralocorticoid receptor antagonists have direct cardioprotective properties, because these drugs reduce mortality in patients with heart failure. In murine models of myocardial infarction, mineralocorticoid receptor antagonists reduce infarct size. Using gen...

Descripción completa

Detalles Bibliográficos
Autores principales:	van den Berg, T. N. A., Deinum, Jaap, Bilos, Albert, Donders, A. Rogier T., Rongen, Gerard A., Riksen, Niels P.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2014
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4214740/ https://www.ncbi.nlm.nih.gov/pubmed/25356826 http://dx.doi.org/10.1371/journal.pone.0111248

Ejemplares similares

Ticagrelor Does Not Inhibit Adenosine Transport at Relevant Concentrations: A Randomized Cross-Over Study in Healthy Subjects In Vivo
por: van den Berg, T. N. A., et al.
Publicado: (2015)

Plasma levels of the cardiovascular protective endogenous nucleoside adenosine are reduced in patients with primary aldosteronism without affecting ischaemia‐reperfusion injury: A prospective case‐control study
por: van den Berg, T. N. A. (Daniëlle), et al.
Publicado: (2019)

Metformin improves survival in intensive care unit patients, but why?
por: Riksen, Niels P, et al.
Publicado: (2013)

Eplerenone ethanol solvate
por: Yang, Qian, et al.
Publicado: (2008)

Impact of Metformin on Endothelial Ischemia-Reperfusion Injury in Humans In Vivo: A Prospective Randomized Open, Blinded-Endpoint Study
por: El Messaoudi, Saloua, et al.
Publicado: (2014)

Effect of eplerenone on parathyroid hormone levels in patients with primary hyperparathyroidism: a randomized, double-blind, placebo-controlled trial
por: Tomaschitz, Andreas, et al.
Publicado: (2012)

Salvia Miltiorrhiza Root Water-Extract (Danshen) Has No Beneficial Effect on Cardiovascular Risk Factors. A Randomized Double-Blind Cross-Over Trial
por: van Poppel, Pleun C. M., et al.
Publicado: (2015)

Eplerenone in the Treatment of Polypoidal Choroidal Vasculopathy
por: Kapoor, Kapil G., et al.
Publicado: (2015)

Eplerenone: The Multifaceted Drug in Cardiovascular Pharmacology
por: Pradhan, Akshyaya, et al.
Publicado: (2020)

Eplerenone use in primary aldosteronism during pregnancy
por: Gunganah, Kirun, et al.
Publicado: (2015)

Eplerenone Treatment in Chronic Central Serous Chorioretinopathy
por: Iqbal, Faisal, et al.
Publicado: (2021)

Effect of Eplerenone on the Glomerular Filtration Rate (GFR) in Primary Aldosteronism: Sequential Changes in the GFR During Preoperative Eplerenone Treatment to Subsequent Adrenalectomy
por: Nakano, Yujiro, et al.
Publicado: (2018)

Rationale for treating oedema in Duchenne muscular dystrophy with eplerenone
por: LEHMANN-HORN, FRANK, et al.
Publicado: (2012)

Possible dose-dependent effect of eplerenone on intraocular pressure
por: Razavi, Seyedeh Mehrsa Sadat, et al.
Publicado: (2023)

The effect of eplerenone on the renin‐angiotensin‐aldosterone system of rats with thyroid dysfunction
por: Dizaye, Kawa, et al.
Publicado: (2019)

A randomized controlled trial of eplerenone in asymptomatic phospholamban p.Arg14del carriers
por: de Brouwer, Remco, et al.
Publicado: (2023)

The Influence of Ionizing Radiation, Temperature, and Light on Eplerenone in the Solid State
por: Dettlaff, Katarzyna, et al.
Publicado: (2014)

Eplerenone in the treatment of central serous chorioretinopathy: a review of the literature
por: Chatziralli, Irini, et al.
Publicado: (2018)

Lack of efficacy of eplerenone for treatment of active central serous chorioretinopathy
por: Sadda, Srinivas R.
Publicado: (2020)

Eplerenone nanocrystals engineered by controlled crystallization for enhanced oral bioavailability
por: Khan, Muhammad Ayub, et al.
Publicado: (2021)

Bilateral bullous central serous chorioretinopathy treated with PDT and eplerenone
por: Anderson, William J., et al.
Publicado: (2022)

A new treatment approach – Eplerenone - in central serous chorioretinopathy - Case report
por: Cioboata, M, et al.
Publicado: (2016)

Eplerenone Implantation Improved Adipose Dysfunction Averting RAAS Activation and Cell Division
por: Vecchiola, Andrea, et al.
Publicado: (2020)

Long-term Resolution of Blinding Polypoidal Choroidal Vasculopathy with Recurrent Bilateral Central Involvement by Low-dose Oral Eplerenone Treatment
por: Bialasiewicz, Alexander Arthur, et al.
Publicado: (2016)

Ischaemic Preconditioning and Postconditioning do not Affect Adenosine A(1) and A(2A) Receptor Sensitivity
por: Riksen, Niels P., et al.
Publicado: (2009)

Oral levosimendan in amyotrophic lateral sclerosis: a phase II multicentre, randomised, double-blind, placebo-controlled trial
por: Al-Chalabi, Ammar, et al.
Publicado: (2019)

Differential effects of eplerenone versus amlodipine on muscle metaboreflex function in hypertensive humans
por: Peri‐Okonny, Poghni A., et al.
Publicado: (2021)

Cost-effectiveness of eplerenone in patients with systolic heart failure and mild symptoms
por: Lee, Dawn, et al.
Publicado: (2014)

Degradation Pathway for Eplerenone by Validated Stability Indicating UP-LC Method
por: Sudhakar Babu, Kondru, et al.
Publicado: (2012)

Database Analysis of Eplerenone Use in Japanese Hypertensive Patients in Clinical Practice
por: Takahashi, Shoko, et al.
Publicado: (2019)

Synthesis and Physicochemical Characterization of the Process-Related Impurities of Eplerenone, an Antihypertensive Drug
por: Dams, Iwona, et al.
Publicado: (2017)

Cost-effectiveness of Eplerenone in treatment of cardiovascular diseases: a systematic review
por: Mobaraki, Hossein, et al.
Publicado: (2017)

Real-world practice patterns of eplerenone use for central serous chorioretinopathy
por: Venkatesh, Ramesh, et al.
Publicado: (2023)

Routine Clinical Practice Treatment Outcomes of Eplerenone in Acute and Chronic Central Serous Chorioretinopathy
por: Fasler, Katrin, et al.
Publicado: (2021)

Design of the Park-in-Shape study: a phase II double blind randomized controlled trial evaluating the effects of exercise on motor and non-motor symptoms in Parkinson’s disease
por: van der Kolk, Nicolien M, et al.
Publicado: (2015)

Effect of Eplerenone on Diastolic Function in Women Receiving Anthracycline-Based Chemotherapy for Breast Cancer
por: Davis, Margot K., et al.
Publicado: (2019)

Short-term eplerenone for treatment of chronic central serous chorioretinopathy; a prospective study
por: Moein, Hamid-Reza, et al.
Publicado: (2019)

(23)Na MRI and myometry to compare eplerenone vs. glucocorticoid treatment in Duchenne dystrophy
por: A. Glemser, Philip, et al.
Publicado: (2017)

Effects of bright light therapy for depression during pregnancy: a randomised, double-blind controlled trial
por: Bais, Babette, et al.
Publicado: (2020)

What if there is no prospective, double blind, randomised trial?
por: de Groot, J. R.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_jbtag0bdtjd3elui4vikjcd4mg